Can new CF drugs tame diabetes? study investigates
NCT ID NCT07102043
Summary
This study aims to understand if a specific type of drug for cystic fibrosis (CFTR modulators) can improve how the body handles blood sugar in people who also have cystic fibrosis-related diabetes (CFRD). Researchers will compare two groups of people with CFRD: those taking the CFTR modulator drug and those who are not eligible for it. Participants will undergo a detailed meal test to measure how their bodies process sugar and insulin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS-RELATED DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 352294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.